Haemophilus B Conjugate (Prp-T) Vaccine Dosage
Medically reviewed by Drugs.com. Last updated on Dec 4, 2023.
Usual Pediatric Dose for:
Additional dosage information:
Usual Pediatric Dose for Haemophilus influenzae Prophylaxis
2 months to 5 years:
4 dose series:
3 primary doses of 0.5 mL, IM, at 2, 4 and 6 months of age
1 booster dose of 0.5 mL, IM, at 15 to 18 months of age
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
Safety and efficacy have not been established in patients younger than 6 weeks.
To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS) at: https://vaers.hhs.gov
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- Inject IM into the anterolateral aspect of the thigh or deltoid.
- Do not administer intravenously, intradermally, or subcutaneously.
Storage requirements:
- Refrigerate; do not freeze.
- Protect from light.
Reconstitution/preparation techniques:
- The manufacturer product information should be consulted.
IV compatibility:
- Do not mix with other products.
More about haemophilus b conjugate (prp-t) vaccine
- Check interactions
- Compare alternatives
- Side effects
- During pregnancy
- Drug class: bacterial vaccines
- En español
Patient resources
- Haemophilus b conjugate (PRP-T) vaccine drug information
- Haemophilus b conjugate vaccine (Advanced Reading)
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
